Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 26Lymphoma, Large B-Cell, Diffuse 19Burkitt Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell, Peripheral 8Lymphoma, Follicular 8Lymphoma, B-Cell 7Lymphoma 7Neoplasms 5Lymphoma, Non-Hodgkin 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Leukemia, Biphenotypic, Acute 3Recurrence 2Prostatic Neoplasms, Castration-Resistant 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Ovarian Neoplasms 2Myasthenia Gravis 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Diseases 1Prostate Cancer Metastatic 1Prostate Adenocarcinoma 1

Interventions

pembrolizumab 5fludarabine 2enfortumab vedotin 2darolutamide 2atezolizumab 2aldesleukin 2Riluzole 2Nivolumab 2Mitomycin 2Fecal Microbiota Transplantation 2Cyclophosphamide 2vedolizumab 1relatlimab 1prednylidene 1olaparib 1lenvatinib 1deltacortene 1cabozantinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Tadalafil 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Rivaroxaban 1Radiosurgery 1Radiation Dose Hypofractionation 1Pregnancy Tests 1Prednisone 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Urogenital Neoplasms × Prednisone × Clear all
NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡